Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva maps authorisation and manufacturing plans on the heels of positive Phase III Covid-19 vaccine data.
By
Materials
Latest in
Materials
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
By
Partner content
How medical-grade silicone can transform transdermal drug delivery
Delivering therapeutic drugs by applying substances to the skin is a practise that dates back thousands of years, but is…